By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EPIRUS Biopharmaceuticals 

699 Boylston Street
11th Floor
Boston  Massachusetts   02116  U.S.A.
Phone: n/a Fax: n/a


Company News
EPIRUS Biopharmaceuticals To Present At Leerink Global Healthcare Conference 2/5/2015 11:40:12 AM
EPIRUS Biopharmaceuticals Prices $48 Million Public Offering Of Common Stock 1/30/2015 10:59:36 AM
EPIRUS Biopharmaceuticals Announces Proposed Public Offering Of Common Stock 1/27/2015 12:45:46 PM
EPIRUS Biopharmaceuticals Seeks British Columbia Securities Commission Order That It Is No Longer A Reporting Issuer 12/12/2014 10:52:04 AM
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014 11:30:15 AM
Data From EPIRUS Biopharmaceuticals’ Phase 3 Study Of BOW015, A Biosimilar Infliximab, To Be Presented As A Late Breaking Poster At American College of Rheumatology Annual Meeting 11/17/2014 5:18:03 PM
EPIRUS Biopharmaceuticals Reports Third Quarter Results And Provides Corporate Update 11/11/2014 9:15:12 AM
EPIRUS Biopharmaceuticals And Livzon Mabpharm Enter Collaboration Agreement For China 9/25/2014 10:08:34 AM
EPIRUS Biopharmaceuticals Announces Positive 58 Week Follow Up Data For BOW015 For Treatment Of Rheumatoid Arthritis 9/23/2014 10:40:47 AM
EPIRUS Biopharmaceuticals To Present At NewsMakers In The Biotech Industry Conference 9/22/2014 9:25:53 AM